marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
Syndax Pharmaceuticals General and Administrative Expenses 2011-2024 | SNDX
Annual General and Administrative Expenses Syndax Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.9 M | 33.3 M | 25.2 M | 22.5 M | 16.1 M | 17.3 M | 15.9 M | 13.3 M | 11.6 M | 11.2 M | 5.36 M | 3.49 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 66.9 M | 3.49 M | 20.2 M |
Quarterly General and Administrative Expenses Syndax Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.1 M | 29.1 M | 23 M | - | 17.3 M | 14.9 M | 12 M | - | 8.24 M | 7.99 M | 6.84 M | - | 6.8 M | 5.84 M | 5.67 M | 4.72 M | 5.82 M | 6.05 M | 5.92 M | 5.08 M | 3.6 M | 3.46 M | 3.91 M | 3.89 M | 4.12 M | 4.48 M | 4.79 M | 4.08 M | 3.56 M | 4.28 M | 3.93 M | 2.97 M | 3.27 M | 2.81 M | 4.27 M | 2.4 M | 3.2 M | 3.29 M | 2.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31.1 M | 2.4 M | 7.37 M |